Department of Biology, College of Education for Pure Sciences, Al-Muthanna University, Samawah, Iraq.
International Journal of Science and Research Archive, 2026, 18(01), 031-036
Article DOI: 10.30574/ijsra.2026.18.1.0012
Received on 24 November 2025; revised on 03 December 2025; accepted on 05 January 2026
Drug resistance is a crisis among major pathogens such as Streptococcus pneumonia (S. pneuomonia). The aim of this study was assessment of synergistic effects of amoxicillin and paeonol checkerboard assay on S. pneumonia. S. pneumonia isolates were resistant to several antibiotics. By combining peonol with amoxicillin, the MIC for amoxicillin alone decreased significantly compared to that of stand-alone amoxicillin. For example, the MIC for amoxicillin when combined with peonol ranged from 0.015 to 0.5 μg/mL, which corresponds to an approximate 8-16 fold decrease of amoxicillin MIC in some samples. Likewise, the average MIC of peonol decreased from approximately 2 mg/mL to an MIC of 0.125 mg/mL when combined with amoxicillin. The results calculated by FIC indices for all bacterial isolates that were exposed to both compounds demonstrated that 15 (75%) of bacteria tested indicated synergy (0.5≤FIC); thus indicating the development of strong synergistic effects between peonol and amoxicillin, while 5 (25%) indicated addition (1≥FIC>0.5) and no strain showed indifference (>1 FIC). No strains showed antagonistic interactions. Therefore, paeonol had good synergistic effect with amoxicillin.
Streptococcus pneumonia; Synergistic effects; Peonol; Amoxicillin
Get Your e Certificate of Publication using below link
Preview Article PDF
Fouad Qasim Jubair Al-Zayadi and Mohammed Mutashar Yasir. Antibacterial effects of peonol in combination with amoxicillin against Streptococcus pneumonia clinical isolates. International Journal of Science and Research Archive, 2026, 18(01), 031-036. Article DOI: https://doi.org/10.30574/ijsra.2026.18.1.0012.
Copyright © 2026 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0







